And one more beta blocker on the shelf....BD
The U.S. Food and Drug Administration has approved Bystolic (nebivolol) for the treatment of high blood pressure.
Bystolic is a beta blocker, a well-established class of medications that reduces blood pressure by reducing the force with which the heart pumps. It is a new drug not previously approved in the United States.
Nearly one in three adults in the United States has high blood pressure, also called hypertension, which can increase the risks for stroke, heart failure, heart attack, kidney failure, and death.